Stantec (STN) Tops Q3 Earnings and Revenue Estimates

Stantec (STN) reported Q3 earnings of $1.35 per share, beating estimates of $1.26. Revenue was $1.33 billion, exceeding expectations. The company has surpassed EPS estimates four times in the last year. Shares are down 20% YTD. Future stock performance may depend on management's commentary and earnings outlook.

Original reporting
Published Nov 12, 2026, 11:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 8:41 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$STN
Bullish
medium confidence
Mentioned
$STN
Relevance
7/10
AlphAI data visualization · based on finance.yahoo.com
Decision brief

The 30-second read

$STNBullishMed
01

Why it matters

The earnings beat provides fresh data for traders; however, the modest revenue beat and existing underperformance suggest limited upside.

02

Market read

Earnings surprise offers a short‑term trading edge, but broader market impact is modest.

03

What to watch

Potential weakness in future guidance and the company's Zacks Rank #3 (Hold) may temper enthusiasm.

Relevance 7/10Novelty 8/10Timing: after-hours

Background

Stantec is a mid-cap engineering and design firm listed on the NYSE under ticker STN.

Company-level read

Ticker impact

$STNBullishMedium confidence
Context

Stantec reported Q3 earnings of $1.35 EPS, beating the $1.26 consensus and revenue of $1.33B, surpassing estimates.

Expected impact

likely upward pressure as the market prices in the earnings beat

Evidence & confidence

The surprise EPS beat of 7.1% and revenue beat of 2.4% provide fresh positive data, but the company has underperformed YTD, limiting upside.

Market effects

The engineering services sector may see modest support from Stantec's beat, but broader impact is limited.

North American markets may see a slight lift in related infrastructure stocks.

Limited global relevance beyond investors tracking North American engineering firms.

Counterpoint

Despite the beat, the stock could face pressure if investors focus on the 20% YTD decline and lack of guidance uplift.

Key entities

  • Stantec

    Engineering services firm reporting Q3 results.

Related articles

$STNMed

CIBC Keeps Their Buy Rating on Stantec (STN)

CIBC maintained a Buy rating on Stantec (STN) with a C$156.00 price target. ATB Cormark also rated it Buy, while Stifel downgraded to Hold. Stantec reported Q3 revenue of C$2.35B and net profit of C$179.6M, up from C$2.14B and C$150M last year. Insider sentiment is positive.

$STNHighAI 9/10

Stantec (STN) Q3 2026 Earnings Call Transcript

Stantec reported Q3 2026 net revenue of $1.9B, up 9.4% YoY, with 5.3% organic growth. Adjusted EBITDA rose 16.6% to $377M, and adjusted EPS increased 23.5% to $1.89. The company cited strong demand across its segments, including water, energy, and buildings, and raised its full-year guidance for revenue growth and profitability. The backlog grew 12% YoY to $9.2B, with organic growth across all regions and businesses.

$STNHighAI 8/10

Why Stantec Stock Soared on Friday

Stantec (STN) rose 13.5% after reporting Q3 earnings of Cdn$1.89 per share on Cdn$1.9B revenue, beating estimates. Revenue grew 9% YoY, EPS 24%. Backlog grew 12% YoY. Guidance revised to 9-11% revenue growth and 17-19% EPS growth.

$STNMed

Stantec Q3 Earnings Call Highlights

Stantec (STN) reported Q3 net revenue of $5.3B, up 10%, with adjusted EBITDA and EPS growing 15.9% and 19.3% respectively. U.S. revenue rose 11%, driven by water and environmental services. Global backlog reached $9.2B, up 12%. Claims provisions increased to $260M but are insured. The company repurchased 3.4M shares and plans to present a strategic plan on December 8.

$STNHighAI 8/10

Stantec Q3 2026 slides: margins expand to 20.2% on broad growth

Stantec (NYSE:STN) reported Q3 2026 revenue of $1.9B, up 9.4% YoY, with adjusted EBITDA margins expanding to 20.2%. EPS rose 23.5% to $1.89, beating estimates. Growth was broad-based across regions and segments, supported by a $9.2B backlog. The stock traded at $107.39, down 0.18%. Guidance was raised, with adjusted EBITDA margin now expected at 18.3%-18.5%.